Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Terminated × iniparib × Clear all

Phase

Status

Completed 4 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 1

Interventions

Cyclophosphamide 89 pembrolizumab 70 Gemcitabine 67 fludarabine 56 Nivolumab 50 Carboplatin 49 Rituximab 44 Radiotherapy 44 Paclitaxel 43 Cisplatin 43 Docetaxel 42 Lenalidomide 37 Dexamethasone 36 Ipilimumab 34 Cytarabine 31 Radiation 29 Etoposide 29 Azacitidine 28 Temozolomide 27 venetoclax 25 Bevacizumab 25 Bortezomib 23 Pemetrexed 21 Capecitabine 21 fludarabine phosphate 20 Magnetic Resonance Spectroscopy 20 atezolizumab 19 Oxaliplatin 19 Interleukin-2 19 Everolimus 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01551680 2025-02-13

RAPIBE

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 1 Terminated

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡